The CYSLTR2 gene gives cells instructions for a receptor that responds to leukotrienes, which are chemical signals that help control inflammation, blood vessel changes, and some immune reactions. If this signaling does not work normally, these body responses can become less balanced and may affect how certain cells communicate or grow. This gene plays an important role in how your body reacts to inflammatory signals. CYSLTR2 is not a widely known public gene, but it is medically relevant because specific variants have been linked to uveal melanoma, a cancer that starts in the eye.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or guiding processes in the body. Some carry the code for proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence your response to food, stress, and medications. For a deeper look at this topic, visit the LearnHub.
Overview
CYSLTR2Gene function
What if the gene works
The CYSLTR2 gene helps cells respond to leukotrienes, chemical signals involved in inflammation. This supports immune activity and helps control blood vessel tone and muscle tightening in tissues such as the airways.
Risk
What if the gene does not work
If the CYSLTR2 gene works less well, cells may respond abnormally to some inflammation signals. Milder variants may slightly change receptor activity, while more severe variants can more clearly disrupt this cell communication.
Treatment
What does that mean for your treatment
No treatment or management approach based specifically on the CYSLTR2 gene is currently established in clinical guidelines. Researchers are studying the CYSLTR2 gene as a potential drug target and biomarker, especially in uveal melanoma.
Conditions associated with CYSLTR2
Gene function
What if the gene works
In the immune system, the CYSLTR2 gene helps cells notice chemical messages linked to normal inflammation. It makes a cell surface receiver for leukotrienes, which are messenger molecules that help guide swelling, blood flow, and other local responses. This background explains what the CYSLTR2 gene does in the body during routine immune signaling.
The CYSLTR2 gene makes a receiver on the cell surface that binds leukotrienes. When these messengers attach, the cell can detect signals from nearby tissue.
After leukotrienes bind, CYSLTR2 passes that message into the cell. This helps switch on pathways that guide cell behavior during a normal immune response.
Many immune cells use CYSLTR2 signals to adjust how active they are and where they move. This supports a more coordinated local response.
CYSLTR2 signaling helps control how blood vessels react to inflammatory messages. It supports local changes in vessel tone and fluid movement that help organize immune activity.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental factors. Many variants do not produce any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYSLTR2 gene can change the shape or activity of its cell-surface receptor, which helps explain how CYSLTR2 gene variants affect cell signaling. Some variants leave the receptor partly or constantly switched on, while others weaken signaling, destabilize the protein, or keep it from reaching the cell surface. These effects can range from mild to more severe, depending on the exact DNA change.
How variants are linked to conditions
When doctors look at variants in the CYSLTR2 gene and health conditions, the clearest link is uveal melanoma, a melanoma that starts in the eye. Similar acquired variants have also been reported in some blue nevi and related pigmented tumors. These changes are usually found only in tumor cells, so they do not usually point to an inherited family risk.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CYSLTR2 gene itself. In practice, any effect depends a lot on the exact gene change and whether it is inherited or found only in tumor cells, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of CYSLTR2 variants
There is not yet a broadly confirmed, disease-specific CYSLTR2 inheritance pattern in human genetics, so how CYSLTR2 variants are inherited in relation to a clearly defined inherited condition remains under study. The CYSLTR2 gene is located on chromosome 13, which is an autosome, so each person inherits one copy of this gene from each parent.
What does my CYSLTR2 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking CYSLTR2 to a specific genetic condition in families. If you have a CYSLTR2 result, what it means for relatives depends a lot on the exact change found and whether it was present only in tumor cells or in the body’s cells more broadly.
Genetic information
Genetic testing
How you find out about variants
Finding out about variants in the CYSLTR2 gene usually involves CYSLTR2 genetic testing on a blood sample, saliva sample, or a piece of tumor tissue. A lab reads the gene’s DNA code and compares it with the usual sequence to look for changes that may help clarify a diagnosis or guide care.
When should I consider getting a genetic test?
There is not yet a broadly established reason to have a CYSLTR2 genetic test on its own. Testing decisions are usually made with a doctor or genetic counselor based on your personal health history, family history, and the larger question the testing is meant to answer.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific variant involved. Over time, factors such as lifestyle, environment, age, and medical history also shape how the body works. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same medication works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences may affect the way a person responds to medication. By studying patterns between genes and drugs, it helps clarify why the same treatment can work differently from one person to another. For many medicines, genes play a part in both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the CYSLTR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so concerns about side effects, new symptoms, or treatment changes are best discussed with your doctor. Research on the CYSLTR2 gene is mainly focused on its role in certain tumors, not on routine medication response in everyday care.